Journal article
Paradoxical decrease in isoprostane and increase in superoxide dismutase following CPAP withdrawal in OSA.
- Abstract:
-
We thank Monneret and Bonnefont-Rousselot for their commentary. Our controlled trial design overcomes most of their concerns of course; any failure of assay techniques would not have produced a biased result, but in fact would have decreased the chances of finding any between-group effects. In our study we observed a statistically significant decrease in urinary F2-isoprostanes following the withdrawal of CPAP treatment in patients with obstructive sleep apnoea (CPAP), in a randomised, two-we...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Accepted manuscript, pdf, 109.4KB)
-
- Publisher copy:
- 10.1183/13993003.01725-2015
Authors
Bibliographic Details
- Publisher:
- European Respiratory Society Publisher's website
- Journal:
- European Respiratory Journal Journal website
- Volume:
- 47
- Issue:
- 3
- Pages:
- 1014-1015
- Publication date:
- 2016-02-29
- Acceptance date:
- 2015-10-25
- DOI:
- EISSN:
-
1399-3003
- ISSN:
-
0903-1936
Item Description
- Language:
- English
- Pubs id:
-
pubs:609110
- UUID:
-
uuid:05f772e6-3a5a-4c63-a4ee-eb6ac7d16dd6
- Local pid:
- pubs:609110
- Source identifiers:
-
609110
- Deposit date:
- 2016-03-29
Terms of use
- Copyright holder:
- European Respiratory Society
- Copyright date:
- 2016
- Notes:
- Copyright © ERS 2016. This is the accepted manuscript version of the article. The final version is available online from the European Respiratory Society at: https://doi.org/10.1183/13993003.01725-2015
Metrics
If you are the owner of this record, you can report an update to it here: Report update to this record